MedPage Today on MSN
Sniffing Out the Optimal Radiation Dose for Head and Neck Cancer
Sense of smell in patients with head and neck cancer began to deteriorate at a radiation dose of 22 Gy and increased in a ...
Dyspareunia affects women of all ages with cancer, so assess pain location, intensity, and dryness, as well as partner ...
TipRanks on MSN
Can-Fite BioPharma secures Brazilian patent for A3AR-based sexual dysfunction therapy
The latest update is out from Can-Fite BioPharma ( (CANF) ).
The Punch on MSN
Emergence of HIFU treatment for prostate cancer, tumours, a game-changer – Specialists
Discover HIFU treatment, a non-invasive game-changer for prostate cancer and tumors. This precision therapy offers faster ...
Possible Reasons, and The Best Labs for Fatigue Key Takeaways: Fatigue describes more than just feeling sleepy — it’s a ...
Cognitive dysfunction in kidney cancer survivors is linked to treatment burden, stress, and fatigue, affecting daily ...
1don MSNOpinion
Why Shrink Bots spell trouble
AI in psychiatry is expected to deliver big – “whatever ails psychiatry, AI promises a cure” – writes Daniel Oberhaus in The ...
Long COVID—defined as symptoms persisting ≥ 2 months beyond acute SARS-CoV-2 infection without alternative explanation—now ...
While our furry companions may live longer, they also face a higher risk of developing harmful conditions, like "dog dementia ...
A possible new treatment for impaired brain blood flow and related dementias is on the horizon. Research by scientists at the ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting ...
The FDA has approved aficamten (Myqorzo; Cytokinetics), a cardiac myosin inhibitor, for adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results